Lesson 7.1: Asthma and COPD

Introduction

In this lesson, we will explore two common but complex respiratory conditions: Asthma and Chronic Obstructive Pulmonary Disease (COPD). The objective of this lesson is to provide a thorough understanding of the stepwise management of these diseases, their exacerbations, inhaler selection, the difference between controller and rescue therapy, and chronic monitoring strategies. By the end of this lesson, you will be equipped to classify the severity of both conditions and apply appropriate management strategies in clinical practice.

Learning Objectives

• Understand and execute stepwise management of asthma and COPD, including exacerbations.
• Make informed decisions on inhaler selection, emphasizing the differences between controller and rescue therapies and the importance of chronic monitoring.
• Classify the severity of asthma and COPD, identifying suitable stepwise therapy for each.
• Effectively manage exacerbations and adjust chronic therapy based on control levels.
• Grasp the essential concepts and terminology related to asthma and COPD.

Stepwise Management of Asthma

Asthma is a chronic inflammatory disease characterized by wheezing, breathlessness, chest tightness, and coughing. It is essential to recognize the symptoms early for effective management. Asthma management is typically broken down into steps based on the severity and frequency of symptoms.

Classification of Asthma Severity

The classification of asthma is divided into four categories: intermittent, mild persistent, moderate persistent, and severe persistent. This classification helps guide treatment options.

1. Intermittent: Symptoms occur twice a week or less, with no nighttime awakenings. Peak expiratory flow (PEF) is normal between exacerbations.
2. Mild Persistent: Symptoms occur more than twice a week but less than once daily. Nighttime awakening occurs 1-2 times a month.
3. Moderate Persistent: Symptoms occur daily, and nighttime awakenings occur 3-4 times a month.
4. Severe Persistent: Symptoms are continuous, with frequent nighttime awakenings, impacting daily activities.

Stepwise Treatment Approach

The management of asthma is structured in a stepwise approach, which assists in tailoring treatment based on the patient's symptoms and severity classification:

• Step 1: As-needed low-dose inhaled corticosteroids (ICS) or a short-acting beta-agonist (SABA).
• Step 2: Daily low-dose ICS for mild persistent asthma.
• Step 3: Daily low-dose ICS with a long-acting beta-agonist (LABA) or medium-dose ICS alone.
• Step 4: A higher dose of ICS with a LABA for moderate persistent asthma.
• Step 5: Refer to specialists. Consider add-on therapies like monoclonal antibodies.

Worked Example 1

Consider a 20-year-old patient diagnosed with asthma who experiences symptoms 3-4 times a week, including nighttime awakenings 2-3 times a month. According to the classification, this patient is categorized as having moderate persistent asthma. The appropriate management strategy would initiate with Step 3:

• Controller therapy: A medium-dose inhaled corticosteroid with a long-acting beta agonist is indicated for control.
• Rescue therapy: The patient should have a SABA available for use during an asthma attack or if symptoms worsen.

Common Misconceptions

One common misconception is that asthma is purely a childhood condition. While many children are diagnosed early, asthma can affect individuals at any age, and symptoms can persist into adulthood or develop later in life.

COPD Overview

Chronic Obstructive Pulmonary Disease (COPD) refers to a group of progressive lung diseases, primarily emphysema and chronic bronchitis. COPD is characterized by airflow limitation and is usually a result of long-term exposure to irritants, most notably tobacco smoke.

Classification of COPD Severity

COPD severity is classified according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines, which provides a grading based on the patient's post-bronchodilator FEV1 (forced expiratory volume in 1 second).

• GOLD 1 (Mild): FEV1 > 80% predicted.
• GOLD 2 (Moderate): 50% < FEV1 < 80% predicted.
• GOLD 3 (Severe): 30% < FEV1 < 50% predicted.
• GOLD 4 (Very Severe): FEV1 < 30% predicted.

Stepwise Treatment Approach

The treatment for COPD involves both pharmacological and non-pharmacological strategies:

1. Bronchodilators (short-acting and long-acting) are the cornerstone of COPD management.
2. Inhaled corticosteroids (ICS) can be added if symptoms are inadequately controlled.
3. For patients with severe COPD and exacerbations, consider long-term oxygen therapy.
4. Pulmonary rehabilitation and smoking cessation strategies must be emphasized.

Worked Example 2

Consider a 65-year-old patient with a history of heavy smoking, diagnosed with COPD. Upon evaluation, the patient has an FEV1 of 45% predicted, placing them in GOLD 3 (Severe) category. Management should involve:

• Step 1: Initiate a long-acting bronchodilator (LABA or LAMA).
• Step 2: If further treatment is required, add ICS to improve symptom control and reduce the frequency of exacerbations.

Inhaler Selection: Controller vs. Rescue Therapy

Inhalers come in several types, and understanding the differences between controller and rescue medications is paramount for effective management.

• Controller Inhalers: These are taken daily to maintain asthma and COPD control. They often include inhaled corticosteroids and long-acting bronchodilators.
• Rescue Inhalers: These are used on an as-needed basis during an exacerbation. They primarily consist of short-acting beta-agonists (SABAs).

Managing Exacerbations

Exacerbations of asthma and COPD require prompt recognition and management to alleviate symptoms and prevent deterioration.

Asthma Exacerbation Management

Asthma attacks can rapidly progress; therefore, recognizing early symptoms such as decreased peak flow and increased shortness of breath is essential. Initial treatment measures include:

• Increasing SABA use.
• Considering a short course of oral corticosteroids if symptoms are severe.
• Monitoring peak flow and symptoms consistently.

COPD Exacerbation Management

Management typically involves increasing bronchodilator therapy and considering the use of systemic corticosteroids and antibiotics for bacterial infections. Patients should be advised to seek medical help for worsening symptoms, such as increased sputum production, change in sputum color, and worsening dyspnea.

Conclusion

In conclusion, understanding the complexities of asthma and COPD, including their management strategies, classification, and treatment approaches, is crucial for healthcare providers. With effective stepwise management, including the appropriate use of inhalers and the ability to recognize and respond to exacerbations, patients can achieve better control of their respiratory conditions, improving their quality of life.

Study Notes

• Asthma and COPD represent chronic respiratory conditions with distinct management strategies.
• Stepwise management involves initial assessment, classification of severity, and escalation of treatment based on symptom control.
• Differentiate between controller and rescue inhalers for asthma and COPD management.
• Regular monitoring and management of exacerbations are vital to prevent deterioration in both conditions.
• Effective patient education is essential for successful long-term management.